• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Guided Therapeutics Inc (OP:GTHP)

    0.1700 UNCHANGED
    Delayed Quote Updated: 10:04 AM EDT, Oct 23, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 181
    Open 0.1700
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 0.1700
    Today's Range 0.1700 - 0.1700
    52wk Range 0.1373 - 0.5400
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Guided Therapeutics Reaches Collaborative Agreement with Türkiye’s Ministry of Health to Become Primary Screening Test for Cervical Cancer
    From Guided Therapeutics
    Via Business Wire
    News headline image
    Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor
    From Guided Therapeutics, Inc.
    Via Business Wire

    Performance

    52-Week Range 68.5% below 52-week high
    0.1700
    0.1452W Low 0.5452W High
    1 Week 26.7% below 1-week high
    0.141W Low 0.231W High

    Guided Therapeutics Inc (GTHP) traded between $0.14 and $0.54 over the past 52 weeks and last traded at $0.17, 68.5% below its 52-week high. Over the past week it ranged between $0.14 and $0.23.

    Past 12 Months
    -10.5%
    -30.6%
    -34.6%
    -15.0%
    -68.5%
    -26.1%
    1W -$0.02
    1M -$0.07
    3M -$0.09
    6M -$0.03
    YTD -$0.37
    1Y -$0.06

    GTHP was -26.1% over the past year, -15.0% over six months, -68.5% year to date, -10.5% in the last week.

    12 Months vs Market
    GTHP
    -26.1%
    DIA
    +12.0%
    SPY
    +13.9%
    QQQ
    +16.5%
    IWM
    +13.2%

    Over the past 12 months GTHP returned -26.1% versus DIA (Dow) +12.0%, SPY (S&P 500) +13.9%, QQQ (Nasdaq 100) +16.5% and IWM (Russell 2000) +13.2%.

    Volume & Liquidity 0.01× 3-mo avg
    Today 181 3-mo avg 34.1K
    1W
    100.2K
    1M
    80.2K
    3M
    34.1K
    6M
    23.1K
    YTD
    20.7K
    1Y
    19.6K

    GTHP most recently traded 181 shares against a 3-month average daily volume of 34.1K.

    More News

    Read More
    News headline image
    Guided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments Corporation
    From Guided Therapeutics, Inc.
    Via Business Wire
    News headline image
    Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA
    From Guided Therapeutics
    Via Business Wire
    News headline image
    Guided Therapeutics Provides Updates on FDA Application Study Results, 2025 Earnings Increase and Successful Warrant Offering
    From Guided Therapeutics, Inc.
    Via Business Wire
    News headline image
    Analysis of Guided Therapeutics' FDA Study Data Reveals Compelling Clinical Need for LuViva
    From Guided Therapeutics, Inc.
    Via Business Wire
    News headline image
    Guided Therapeutics Receives $88,000 Payment as Third Installment of $700,000 Purchase Order with Chinese Distributor
    From Guided Therapeutics, Inc.
    Via Business Wire
    News headline image
    Guided Therapeutics Inks Initial $200,000 Deal with New Distribution Partner Yuanshuo Medical Instruments Corporation
    From Guided Therapeutics, Inc.
    Via Business Wire
    News headline image
    Guided Therapeutics Receives $70,000 -- Its Second of Nine Payments Totaling $700,000 -- from New Chinese Distribution Partner that Provides Products for 2 Million Annual Cervical Cancer Screenings
    From Guided Therapeutics, Inc.
    Via Business Wire
    News headline image
    Guided Therapeutics Provides Update on Completion of US FDA Clinical Trial
    From Guided Therapeutics, Inc.
    Via Business Wire
    News headline image
    Guided Therapeutics Makes Initial Shipment to New Chinese Distribution Partner Hangzhou Dongye Medical Technology, Ltd.
    From Guided Therapeutics, Inc.
    Via Business Wire
    News headline image
    Guided Therapeutics Receives $700,000 Purchase Order and Initial Payment from New Chinese Distributor
    From Guided Therapeutics, Inc.
    Via Business Wire
    News headline image
    Guided Therapeutics Receives $100,000 from SMI’s Investment Partners to Continue Commercialization Process of LuViva in China
    From Guided Therapeutics, Inc.
    Via Business Wire
    News headline image
    Guided Therapeutics Receives Order and Full Payment From Indonesia for 4 LuViva Systems and 1,200 Disposables
    From Guided Therapeutics, Inc.
    Via Business Wire
    News headline image
    Guided Therapeutics Announces Filing of Application for NMPA Approval to Market and Sell LuViva in China
    From Guided Therapeutics, Inc.
    Via Business Wire
    News headline image
    Guided Therapeutics’ Announces Data from Chinese NMPA Clinical Study Signed Off by All Four Clinical Sites With Better Than Expected Results
    From Guided Therapeutics, Inc.
    Via Business Wire
    News headline image
    Leading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial Results
    From Guided Therapeutics, Inc.
    Via Business Wire
    News headline image
    Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval
    From Guided Therapeutics, Inc.
    Via Business Wire
    News headline image
    Guided Therapeutics Provides Update on Start of Clinical Trial for US FDA Approval
    From Guided Therapeutics, Inc.
    Via Business Wire
    News headline image
    Guided Therapeutics Announces New Agreement and Purchase Orders from Shandong Yaohua Medical Instrument Corporation
    From Guided Therapeutics, Inc.
    Via Business Wire
    News headline image
    Guided Therapeutics Signs Agreement to Begin Clinical Trial for US FDA Approval
    From Guided Therapeutics, Inc.
    Via Business Wire
    News headline image
    Guided Therapeutics Provides Update of Significant Progress in Chinese Clinical Study for Marketing Approval of the LuViva Advanced Cervical Scan
    From Guided Therapeutics, Inc.
    Via Business Wire
    News headline image
    Guided Therapeutics Closes $3.3 Million Bridge Financing
    From Guided Therapeutics, Inc.
    Via Business Wire
    News headline image
    Guided Therapeutics Receives Institutional Review Board Approval to Start Clinical Study for FDA Approval of the LuViva® Advanced Cervical Scan
    From Guided Therapeutics, Inc.
    Via Business Wire
    News headline image
    Guided Therapeutics Announces Testing Completion of First 150 Patients in Chinese Clinical Study and Receives Milestone Payment of $177,740
    From Guided Therapeutics, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Guided Therapeutics Inc publicly traded?
    Yes, Guided Therapeutics Inc is publicly traded.
    What exchange does Guided Therapeutics Inc trade on?
    Guided Therapeutics Inc trades on the OTC Traded
    What is the ticker symbol for Guided Therapeutics Inc?
    The ticker symbol for Guided Therapeutics Inc is GTHP on the OTC Traded
    What is the current price of Guided Therapeutics Inc?
    The current price of Guided Therapeutics Inc is 0.1700
    When was Guided Therapeutics Inc last traded?
    The last trade of Guided Therapeutics Inc was at 10/23/26 10:04 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.